Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Biomarkers of HPV in Head and Neck Squamous Cell Carcinoma
2012
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
2001
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
HPV testing in cervical screening
2001
Incidence, Duration, and Determinants of Cervical Human Papillomavirus Infection in a Cohort of Colombian Women with Normal Cytological Results
2004
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
2010
Genital human papillomavirus infection in men
2005
The epidemiology of human papillomavirus infections
2005
5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia
2009 StandoutNobel
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Detection of human papillomavirus type 18 E6 and E7‐specific CD4+ T‐helper 1 immunity in relation to health versus disease
2005
The carcinogenicity of human papillomavirus types reflects viral evolution
2005
HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears
2001
Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia
2006
Qualification of ASCUS
2001
Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia
2003
Epidemiologic Profile of Type‐Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica
2005
Global Cancer Statistics, 2002
2005 Standout
High‐risk HPV testing in women with borderline and mild dyskaryosis: long‐term follow‐up data and clinical relevance
2001
Relationships between 80 Human Papillomavirus Genotypes and Different Grades of Cervical Intraepithelial Neoplasia: Association and Causality
2001
Immune responses to human papillomavirus
2005
Human papillomavirus variants and squamous neoplasia of the cervix
2001
Human papillomavirus vaccines
2006
A Prospective Study of Human Papillomavirus (HPV) Type 16 DNA Detection by Polymerase Chain Reaction and Its Association with Acquisition and Persistence of Other HPV Types
2001
Classification of papillomaviruses
2004 StandoutNobel
Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study
1999
Head and neck cancer
2008 Standout
Prevalence of HPV Infection Among Females in the United States
2007 Standout
A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US
2008
The burden of non-communicable diseases in South Africa
2009 Standout
Cervicovaginal Human Papillomavirus Infection in Human Immunodeficiency Virus-1 (HIV)-Positive and High-Risk HIV-Negative Women
1999
Chapter 5: Updating the natural history of HPV and anogenital cancer
2006
Coordinated regulation of myeloid cells by tumours
2012 Standout
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
2002 Standout
Seroprevalence atlas of infections with oncogenic and non‐oncogenic human papillomaviruses in Finland in the 1980s and 1990s
2006
Recent Advances in the Use of Cyclodextrins in Antifungal Formulations
2013
Deficiencies in myeloid antigen‐presenting cells in women with cervical squamous intraepithelial lesions
2006
The epidemiology of genital human papillomavirus infection
2005
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
2010
The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
2005
Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohort
2000
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
2003
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United States
1999
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study
2000
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
2004
The serological response to papillomaviruses
1999
Epigenetics in Cancer
2008 Standout
Acceptability of human papillomavirus self testing in female adolescents
2005
Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004
2009
Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology
2009
Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA–positive atypical squamous cells of undetermined significance: A two-year prospective study
2003
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women
2006
Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
2001
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
The known unknowns of HPV natural history
2011
Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings
2003
Detection of Hypermethylated Genes in Women with and Without Cervical Neoplasia
2005
The causal relation between human papillomavirus and cervical cancer
2002 Standout
The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence
2005
Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus–Like Particles in Human Immunodeficiency Virus (HIV)–Positive and High‐Risk HIV–Negative Women
2003
Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia
2003
Human papillomavirus and cervical cancer
2007 Standout
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
2007
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Combined human papillomavirus DNA and human papillomavirus‐like particle serologic assay to identify women at risk for high‐grade cervical intraepithelial neoplasia
2006
The Natural History of Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Among Young Women in the Guanacaste Cohort Shortly After Initiation of Sexual Life
2007
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Strategies for immunotherapy of cancer
2000
Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type
2007
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
2002
The natural history of cervical HPV infection: unresolved issues
2006
Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort
2004
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Natural History and Possible Reactivation of Human Papillomavirus in Human Immunodeficiency Virus–Positive Women
2005
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction
2001
Seroprevalence of 8 Oncogenic Human Papillomavirus Genotypes and Acquired Immunity Against Reinfection
2014
Papillomavirus detection: Demographic and behavioral characteristics influencing the identification of cervical disease
2000
p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia
2002 Standout
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
2000
Screening for Genital Human Papillomavirus
1999
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections
2002
Molecular Epidemiology of Human Papillomavirus
2008
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
Human Papillomavirus Infection Among Sexually Active Young Women in the United States: Implications for Developing a Vaccination Strategy
2006
A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion
2007
Human Papillomavirus Infection in Men Attending a Sexually Transmitted Disease Clinic
2003
Actual Causes of Death in the United States, 2000
2004 Standout
Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States)
2001
PATHOGENESIS AND TREATMENT OF JUVENILE ONSET RECURRENT RESPIRATORY PAPILLOMATOSIS
2000
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Cost-effectiveness analyses of human papillomavirus vaccination
2007
Clinician's guide to human papillomavirus immunology: knowns and unknowns
2009
Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions
2001
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
2008
Concurrent and Sequential Acquisition of Different Genital Human Papillomavirus Types
2000
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study
2001
Efficacy and other milestones for human papillomavirus vaccine introduction
2004
Infección por los virus del papiloma humano y de la inmunodeficiencia humana como factores de riesgo para el cáncer de cuello uterino en mujeres reclusas
2000
Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical Cancer
1999
Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5]
2005
Heritability of cervical tumours
2000
Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer
2011
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
External Genital Warts: Diagnosis, Treatment, and Prevention
2002
High-risk HPV type-specific clearance rates in cervical screening
2007
Human Papillomaviruses and Cervical Cancer in Bangkok. I. Risk Factors for Invasive Cervical Carcinomas with Human Papillomavirus Types 16 and 18 DNA
2001
QT Interval Prolongation in Future SIDS Victims: A Polysomnographic Study
2008
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta‐analysis of randomised‐controlled trials
2005
Two-Week versus Six-Month Sampling Interval in a Short-Term Natural History Study of Oral HPV Infection in an HIV-Positive Cohort
2010
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Risk factors for rapid-onset cervical cancer
1999
Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?
1999
Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
2010
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women
2006
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
2000
The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus
2007
New Approaches to Immunotherapy for HPV Associated Cancers
2011
Head and Neck Cancer
2020 Standout
RECURRENT RESPIRATORY PAPILLOMATOSIS OF THE LARYNX
2000
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
2002
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2007 Standout
Conazoles
2010
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
2001
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
2013 Standout
Improved Amplification of Genital Human Papillomaviruses
2000
Review: A History of Cyclodextrins
2014 Standout
Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection
2004
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6
2004
Neural Science
2000 StandoutNobel
Human Papillomavirus and Cervical Cancer
2003 Standout
Smokers at Higher Risk for Undetected Antibody for Oncogenic Human Papillomavirus Type 16 Infection
2006
Pharmacology of Systemic Antifungal Agents
2006
Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
2003
A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
2000
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
2020
Characterization of a novel genital human papillomavirus by overlapping PCR: candHPV86 identified in cervicovaginal cells of a woman with cervical neoplasia
2001
The natural history of type-specific human papillomavirus infections in female university students.
2003
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Correlates of the spread of human papillomavirus infection.
2000
In Vitro Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans , and Aspergillus Species to Itraconazole: Global Survey of 9,359 Isolates Tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods
2005
Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
2001
Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects.
2002
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
Genotyping of Human Papillomavirus in Liquid Cytology Cervical Specimens by the PGMY Line Blot Assay and the SPF 10 Line Probe Assay
2002
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Single-Ascending-Dose Pharmacokinetics and Safety of the Novel Broad-Spectrum Antifungal Triazole BAL4815 after Intravenous Infusions (50, 100, and 200 Milligrams) and Oral Administrations (100, 200, and 400 Milligrams) of Its Prodrug, BAL8557, in Healthy Volunteers
2005
2014
Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students
2005
A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies
2003 StandoutNobel
Amphibian Limb Regeneration
1968
Human Papillomavirus
2001
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
2004
Invasive fungal infections: a review of epidemiology and management options
2006
Works of Robert Bierman being referenced
Food Interaction and Steady‐State Pharmacokinetics of Itraconazole Oral Solution in Healthy Volunteers
1998
Risk Factors for Subsequent Cervicovaginal Human Papillomavirus (HPV) Infection and the Protective Role of Antibodies to HPV‐16 Virus‐Like Particles
2002
Development of a Multi-Item Scale to Quantitatively Assess Sexual Behaviors and the Transmission of High- and Low-Risk Human Papillomaviruses
1998
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
1998 Standout
Cisapride: A Gastrointestinal Prokinetic Drug
1994
Enhanced Bioavailability of Itraconazole in Hydroxypropylβ-Cyclodextrin Solution versus Capsules in Healthy Volunteers
1998
Natural History of Cervicovaginal Papillomavirus Infection in Young Women GYF Ho
1998
Polymer-Based Enzyme-Linked Immunosorbent Assay Using Human Papillomavirus Type 16 (HPV16) Virus-Like Particles Detects HPV16 Clade-Specific Serologic Responses
2003
Effects of cortisone and allied adrenal steroids upon limb regeneration in hypophysectomized Triturus viridescens
1956
Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers
1986
Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers
1993
Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women
2004